In particular, this study shows that SCs-derived CCL7 binds to its receptor CCR2 in cancer cells to upregulate the expression of the EMT-related factor TIMP1, while TIMP1 binds to CD63 to enhance the expression of CCL7 in SCs. This evidence concerns the gene CCR2 and cancer.